Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CORT
Stock Latest News
The Fly
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
23h ago
CORT
Premium
The Fly
Corcept Therapeutics price target raised to $110 from $100 at Canaccord
1d ago
CORT
Premium
Class Action
Corcept Faces Investor Suit Over Relacorilant NDA Disclosure
2d ago
CORT
Premium
The Fly
Corcept Therapeutics price target raised to $110 from $100 at Canaccord
2d ago
CORT
Premium
Company Announcements
Corcept Wins FDA Approval for Lifyorli Ovarian Cancer Therapy
2d ago
8K
CORT
Premium
The Fly
Corcept confirms FDA approves Lifyorli for platinum-resistant ovarian cancer
2d ago
CORT
Premium
Market News
Corcept Rockets 48% after FDA Lifyorli Approval — What Does This Mean for CORT Stock?
2d ago
CORT
TEVA
Premium
Ratings
Corcept Therapeutics: Early Lifyorli Approval and Robust Long‑Term Sales Outlook Underpin Buy Rating and $60 Target
2d ago
CORT
Premium
The Fly
Corcept Therapeutics price target lowered to $60 from $67 at H.C. Wainwright
2d ago
CORT
Premium
The Fly
Corcept Therapeutics rises 28.6%
2d ago
CORT
Premium
The Fly
Corcept Therapeutics trading resumes
2d ago
CORT
Premium
The Fly
Corcept Therapeutics up 43% to $48.35 after FDA approves Lifyorli
2d ago
CORT
Premium
The Fly
FDA approves Corcept Therapeutics’ Lifyorli for certain cancers
2d ago
CORT
Premium
The Fly
FDA approves Corcept Therapeutics’ Lifyorli for certain cancers
2d ago
CORT
Premium
The Fly
Corcept Therapeutics jump 10% after FDA approves Lifyorli cancer treatment
2d ago
CORT
Premium
The Fly
Corcept Therapeutics trading halted, volatility trading pause
2d ago
CORT
Premium
The Fly
Corcept Therapeutics management to meet with Piper Sandler
4d ago
CORT
Premium
The Fly
Corcept Therapeutics director buys $3.3M in common stock
8d ago
CORT
Premium
Class Action
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements
15d ago
CORT
Premium
Company Announcements
Corcept Therapeutics Balances Growth With Rising Risks
29d ago
CORT
Premium
The Fly
Corcept Therapeutics price target lowered to $60 from $67 at H.C. Wainwright
1M ago
CORT
Premium
The Fly
Corcept Therapeutics reports Q4 EPS 20c, consensus 33c
1M ago
CORT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
